Valeant's story: a cautionary tale

Mar 21, 2016
The company's CEO stepped down on Monday
Howard Schiller, then interim CEO of Valeant Pharmaceuticals International, Inc., listens during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. 

Bad packaging means $3b in drugs will be wasted this year

Mar 1, 2016
A new report suggests drug makers are profiting from the waste.
A new report suggests drug makers are profiting from the waste.
Peter Macdiarmid/Getty Images

How CVS reined in drug prices

Feb 23, 2016
Its Caremark unit covers some 25 million U.S. customers
Spencer Platt/Getty Images

A push for more transparency in drug research costs

Feb 16, 2016
The industry worries it's a step toward price controls.
Drug companies are not only in the spotlight for price setting, but now they may be required to be transparent about R&D spending. 
Kiran Foster/Flickr

How more generics could relieve sky-high drug prices

Feb 4, 2016
More generics are needed to create competition — but can the FDA approve them fast enough?
With high drug prices, more generics are needed to create competition, but can the FDA is having a hard time keeping up.

Survey shows drug price hikes widespread in industry

Feb 4, 2016
It's not just a few bad players, as Congressional hearing puts drug costs in focus.

Congress turns its attention to high drug prices

Jan 21, 2016
This may actually lower drug costs.

For public good, not for profit.

Support fact-based, independent journalism with a gift to Marketplace today.

Congress aims to give some drugmakers a break

Oct 2, 2015
The push comes even as lawmakers discuss ways to rein in drug prices.